PRELP enhances host innate immunity against the respiratory tract pathogen moraxella catarrhalis

Medicin och livsvetenskap

• leucine-rich repeat proteins 100%
• Moraxella catarrhalis 86%
• Proline 68%
• Respiratory System 60%
• Arginine 59%
• Innate Immunity 59%
• Complement C4b-Binding Protein 23%
• human PRELP protein 16%
• Lung 11%
• Moraxella 11%
• Neutrophils 11%
• Complement Inactivating Agents 10%
• Epithelial Cells 10%
• Serum 9%
• Complement Membrane Attack Complex 9%
• Adventitia 8%
• Myofibroblasts 8%
• Haemophilus influenzae 8%
• A549 Cells 7%
• Bronchoalveolar Lavage Fluid 7%
• varespladib methyl 7%
• Streptococcus pneumoniae 7%
• Respiratory Tract Infections 6%
• Extracellular Matrix 6%
• Membrane Proteins 5%
• Monocytes 5%
• Ligands 5%
• Macrophages 4%
• Bacteria 4%
• Blood Vessels 4%
• Mortality 3%
• Infections 3%
• In Vitro Techniques 3%